The cannabinoids market has witnessed significant growth in recent years, driven by increasing research on the therapeutic potential of cannabinoids and the growing legalization of medical and recreational cannabis use in several countries. Cannabinoids are a group of compounds that interact with the endocannabinoid system in the human body, and are found in the cannabis plant as well as in other sources such as the hemp plant.
The global cannabinoids market is projected to reach USD 89.4 billion by 2026, with a compound annual growth rate (CAGR) of 35.3% during the forecast period, according to a report by ResearchAndMarkets.com. The market is segmented by product type, application, and region.
The product type segment includes THC-dominant, CBD-dominant, and balanced THC/CBD products. THC-dominant products are expected to hold the largest share of the market due to their psychoactive effects, while CBD-dominant products are expected to witness significant growth due to their therapeutic properties and increasing demand for non-psychoactive cannabis products.
The application segment includes medical, recreational, and pharmaceuticals. Medical applications are expected to hold the largest share of the market due to the growing adoption of cannabis-based medicines for various conditions such as chronic pain, epilepsy, and multiple sclerosis.
North America is expected to hold the largest share of the market due to the legalization of medical and recreational cannabis use in several states in the US and Canada. Europe is also expected to witness significant growth due to the increasing adoption of cannabis-based medicines and the legalization of medical cannabis use in several countries.
Key players in the cannabinoids market include GW Pharmaceuticals, Aurora Cannabis, Canopy Growth Corporation, Tilray, Inc., and Aphria, Inc. These companies are focusing on product innovation, research and development, and strategic partnerships to expand their market share and stay competitive in the market.
In conclusion, the cannabinoids market is expected to witness significant growth in the coming years, driven by increasing research on the therapeutic potential of cannabinoids and the growing legalization of medical and recreational cannabis use. Key players in the market are focusing on product innovation and strategic partnerships to stay competitive in the market.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Everest Market Insights journalist was involved in the writing and production of this article.